Flurbiprofen in the treatment of acute gout. A comparison with indomethacin.

The relative efficacy and safety of flurbiprofen (Ansaid, Upjohn) and indomethacin were compared in 29 patients with monoarticular gouty arthritis of less than 48 hours' duration. A loading dose of 400 mg of flurbiprofen or 200 mg of indomethacin was administered for 24 hours, followed by 200 mg of flurbiprofen per day or 100 mg of indomethacin per day for a maximum of five days. Based on global assessment of improvement, at least 50 percent of patients in both treatment groups showed improvement within 24 hours.

An interactive clinical data system.

A clinical data system is under development at the Upjohn Company that will reduce the time lag from patient visit to data availability, data entry errors, and the amount of training required for system use. The system design allows generality for both the study monitor and the biostatistician, editing of the data before entry, simplified forms design, direct entry of textual responses without coding, and a reduced need for special programs. Interactive subsystems allow a user to describe a study to the system, generate tailor-made entry/edit programs for each study, undate the date base, and produce ad hoc reports.